About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Particular HIV Subtype Could Cause Dementia, Says Study

by Aruna on August 31, 2009 at 9:22 AM
Particular HIV Subtype Could Cause Dementia, Says Study

Researchers at Johns Hopkins have found that infections with a particular subtype of HIV increase people's likelihood of developing dementia, compared to infections with other subtypes.

Writing about their findings in the journal Clinical Infectious Diseases, the researchers claimed that theirs is the first study to have shown that the specific type of HIV has any effect on cognitive impairment, one of the most common complications of uncontrolled HIV infection.

Advertisement

In their study report, the researchers highlight the fact that HIV occurs in multiple forms, distinguished by small differences in the virus' genetic sequence and designated by letters A through K.

They point out that certain subtypes appear to cluster in particular areas of the world, which others have been associated with different rates of progression to full blown AIDS.
Advertisement

They also revealed that the majority of the 35 million HIV-infected people worldwide live in sub-Saharan Africa, where subtypes A, C and D dominate.

According to them, nearly half of patients with advanced HIV infections have at least mild cognitive impairments, and about 5 percent have the severe form of cognitive impairment, known as dementia.

Dr. Ned Sacktor, professor of neurology at the Johns Hopkins University School of Medicine and a clinician at the Johns Hopkins Bayview Medical Center, previously found that about 31 percent of patients visiting an infectious disease clinic in the Ugandan capital, Kampala, where subtypes A and D dominate, had dementia.

The finding led him to wonder whether patients with different subtypes had different rates of dementia.

He and his colleagues then studied 60 HIV-infected patients from a Kampala clinic, all of whom had been part of a different study testing the effect of anti-retroviral drugs on cognitive impairment, but had not begun taking the drugs.

After determining each patient's HIV subtype, the researchers performed a battery of neurological and cognitive tests to assess each patient's brain function.

They observed that the majority of the patients had HIV subtypes A or D.

Further analysis by the researchers revealed that, of the 33 subtype A patients, seven had dementia, or about 24 percent.

However, out of the nine patients with subtype D, 8 had dementia, about 89 percent.

"We were amazed to see such a dramatic difference in dementia frequencies between these two subtypes. If this is the case in all of sub-Saharan Africa, HIV-associated dementia may be one of the most common, but thus far unrecognized, dementias worldwide," Sacktor says.

He says that the study indicates that some biological property of each subtype seems to influence the likelihood that infected patients will develop dementia.

Based on their findings, his team hypothesize that subtype D may cause more inflammation and injury in the brain, a possibility they are currently investigating.

Source: ANI
ARU
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest AIDS/HIV News

HIV Vaccine Clinical Trial Initiates in the United States and South Africa
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.
Beauty Salon-Driven Initiative Boosts PrEP Awareness in Fight Against AIDS
In the United States, African American women make up only 26% of female PrEP users, yet they account for 57% of new infections among women.
Immune-Evading HIV Protein Complex Solved
Scientists have made a groundbreaking discovery in the fight against HIV/AIDS with the successful resolution of the enigmatic immune-evading HIV protein complex.
Does Gender Influence Comorbidity Rates in HIV-Positive Smokers
Tailored quit-smoking programs are designed to address the risks associated with comorbidity in individuals living with HIV.
Digital Test Measures HIV Viral Load
DNA editing tool CRISPR-Cas13 helps diagnose and signal the presence of HIV antibodies in HIV patients.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Particular HIV Subtype Could Cause Dementia, Says Study Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests